Director, Clinical Immunology & Allergy
Scientific Director, AllerGen NCE Inc.
Dr. Denburg is the Scientific Director and CEO of AllerGen NCE Inc., whose mandate is to support research, networking, commercialization and capacity building activities that contribute to reducing the morbidity, mortality and socio-economic impact of allergic disease.
Dr. Denburg attended McGill University Medical School (1966-8) and Hebrew University, Jerusalem, Israel (1971) where he received his MD. Subsequently, he received his Fellowship Certification (FRCPC) from the Royal College of Physicians and Surgeons of Canada for the specialties of Internal Medicine (1976) and Hematology (1977).
Currently, Dr. Denburg is Director and Chief of Service of Clinical Immunology and Allergy at Hamilton Health Sciences, McMaster Division. He is a Professor in the Department of Medicine, Faculty of Health Sciences, and holds the William J. Walsh Chair in Medicine. Dr. Denburg is active as a physician, with one of the largest practices in allergy and immunology in Canada. In his educational role, he serves as the primary link between basic and clinical immunology at McMaster, and has mentored numerous students and fellows into leadership roles in the field of allergy and immunology.
Dr. Denburg’s primary research interest is the developmental biology of eosinophils, basophils and mast cells, and their regulation in allergic inflammation; his pioneering investigations on the systemic nature of allergy have had a profound impact on clinical and basic scientific investigations in the field. Dr. Denburg is also a recognized expert on autoimmune diseases such as systemic lupus erythematosus (SLE). He is particularly interested in the neuropsychiatric complications of SLE, and is involved with a large group of co-investigators in studies of immune mechanisms underlying cognitive dysfunction in this disease.
Dr. Denburg has received awards for his ongoing peer-reviewed and funded (Canadian Institutes of Health Research, Canadian Foundation for Innovation, ODCRF) research, including a prestigious Award from the Pharmacia Allergy Research Foundation and the Immunology Research Award (2001) of the Canadian Society of Allergy and Clinical Immunology. Dr. Denburg has been asked to lead various committees and plan research and educational programmes nationally and internationally. He was elected to the Executive Council of the prestigious Collegium Internationale Allergologicum, and is on the Editorial Board of and/or is primary reviewer for the top journals in the field of allergy and immunology globally. His publication list, as well as editorship and contribution to concept formation and education internationally as an opinion leader in allergy and immunology, is extensive, with over 250 peer-reviewed scientific journal articles, reviews and book chapters.